Safety Evaluations of Single Dose of the Olive Secoiridoid <i>S</i>-(−)-Oleocanthal in Swiss Albino Mice

• Main Authors: Abu Bakar Siddique, Judy Ann King, Sharon A. Meyer, Khaldoun Abdelwahed, Belnaser Busnena, Khalid A. El Sayed
• Format: Article
• Language: English
• Published: MDPI AG 2020-01-01
• Series: Nutrients
• Subjects: acute toxicity; extra-virgin olive oil; histopathology; <i>s</i>-(−)-oleocanthal; single dose
• Online Access: https://www.mdpi.com/2072-6643/12/2/314

Epidemiological and clinical studies compellingly showed the ability of Mediterranean diet rich in extra-virgin olive oil (EVOO) to reduce multiple diseases such as cancer, cardiovascular diseases, and aging cognitive functions decline. The <i>S</i>-(&#8722;)-Oleocanthal (OC) is a minor phenolic secoiridoid exclusively found in extra-virgin olive oil (EVOO). OC recently gained notable research attention due to its excellent in vitro and in vivo biological effects against multiple cancers, inflammations, and Alzheimer&#8217;s disease. However, OC safety has not been comprehensively studied yet. This study reports for the first time the detailed safety of oral single OC dose in Swiss albino mice, applying the OECD 420 procedure. Male and female Swiss albino mice (<i>n</i> = 10) were orally treated with a single OC dose of either 10, 250, or 500 mg/kg bodyweight or equivalent volumes of distilled water. Mice fed a regular diet, and carefully observed for 14 days. Further, mice were then sacrificed, blood samples, and organs were collected and subjected to hematological, biochemical, and histological examinations. OC 10 mg/kg oral dose appears to be without adverse effects. Further, 250 mg/kg OC, p.o., is suggested as a possible upper dose for preclinical studies in the future.